7th Advances in Circulating Tumour Cells (ACTC) Meeting

Distinguish 5-methylcytosine (5mC) and 5-hydroxymethylcytosine (5hmC) together with all 4 canonical bases to measure multiple modes of biology from a single 5ng DNA sample, in a single experiment, with high accuracy. Identify novel multimodal biomarkers to gain transformative insights into current and future states of disease.
24 September 2025
to 27 September 2025
Makedonia Palace Hotel
, Thessaloniki
, Greece

Visit biomodal at booth 

#15

About the event

The event aims to bring together Key Opinion Leaders in liquid biopsy, including clinicians, researchers, postgraduate students, and technology providers. Delegates will have the chance to interact, establish fruitful collaborations and present state of the art data and technology innovations in the field in a safe, relaxing and stimulating environment. During intense keynote, oral and poster presentation sessions, mostly unpublished cutting-edge research on the latest achievements, and technical advancements on CTCs, ctDNA and EVs analysis, will be presented. Latest findings on clinical trials based on liquid biopsy will be discussed.

Presenting at the event

The 6-base genome as a tool to reveal novel biomarkers and mechanistic insight in cancer neuroscience

Leonardo Motta, PhD

biomodal

Find the venue

One sample. One workflow. One solution.

Here are the relevant biomodal resources for information. Find poster presentation information, case studies, interviews, and more.

Related resources

Attending from biomodal

Leonardo Motta

Leonardo Motta

Territory Account Manager – UK, Ireland & Nordics
Dirk Bartels

Dirk Bartels, PhD

Business Development Manager
Sascha Seidel

Sascha Seidel, PhD

Scientific Affairs Partner, DACH

Register now

7th Advances Tumour 2025
150471776443

Stay up to date

Explore recent biomodal news and the events that we’ll be attending in the near future.

What are you looking for?